Luís Lopes Madureira Silva Miguel
AuthID: R-000-9J6
21
TITLE: COST-EFFECTIVENESS OF PEMETREXED IN FIRST LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN PORTUGAL Full Text
AUTHORS: Pinto, CG; Manacas, M; Miguel, LS;
PUBLISHED: 2009, SOURCE: VALUE IN HEALTH, VOLUME: 12, ISSUE: 7
AUTHORS: Pinto, CG; Manacas, M; Miguel, LS;
PUBLISHED: 2009, SOURCE: VALUE IN HEALTH, VOLUME: 12, ISSUE: 7
INDEXED IN: WOS CrossRef
22
TITLE: ECONOMIC EVALUATION OF DOCETAXEL IN THE CONTEXT OF BREAST CANCER IN PORTUGAL Full Text
AUTHORS: Pinto, CG; Moreira, A; Miguel, LS; Esteves, S;
PUBLISHED: 2009, SOURCE: VALUE IN HEALTH, VOLUME: 12, ISSUE: 7
AUTHORS: Pinto, CG; Moreira, A; Miguel, LS; Esteves, S;
PUBLISHED: 2009, SOURCE: VALUE IN HEALTH, VOLUME: 12, ISSUE: 7
INDEXED IN: WOS CrossRef
23
TITLE: COST-UTILITY ANALYSIS OF DULOXETINE VERSUS VENLAFAXINE IN THE MANAGEMENT OF MAJOR DEPRESSION IN PORTUGAL Full Text
AUTHORS: Pinto, CG; Barbosa, A; Miguel, LS; Feio, M;
PUBLISHED: 2008, SOURCE: VALUE IN HEALTH, VOLUME: 11, ISSUE: 6
AUTHORS: Pinto, CG; Barbosa, A; Miguel, LS; Feio, M;
PUBLISHED: 2008, SOURCE: VALUE IN HEALTH, VOLUME: 11, ISSUE: 6
INDEXED IN: WOS CrossRef
24
TITLE: The first mover strikes again. Cost-effectiveness of statins and prescribing behavior in Portugal Full Text
AUTHORS: Pinto, CG; Miguel, LS; Paquete, AT;
PUBLISHED: 2008, SOURCE: VALUE IN HEALTH, VOLUME: 11, ISSUE: 3
AUTHORS: Pinto, CG; Miguel, LS; Paquete, AT;
PUBLISHED: 2008, SOURCE: VALUE IN HEALTH, VOLUME: 11, ISSUE: 3
INDEXED IN: WOS CrossRef
25
TITLE: Cost-effectiveness of switching to exemestane (EX) after 2-3 years of adjuvant tamoxifen (T) in postmenopausal (PM) early breast cancer (EBC) Full Text
AUTHORS: Pinto, CG; Castanho, MS; Miguel, LS; Rocha, E;
PUBLISHED: 2007, SOURCE: BREAST, VOLUME: 16
AUTHORS: Pinto, CG; Castanho, MS; Miguel, LS; Rocha, E;
PUBLISHED: 2007, SOURCE: BREAST, VOLUME: 16
INDEXED IN: WOS CrossRef